Decision aid reduces conflict in breast cancer treatment

Decision aid reduces conflict in breast cancer treatment
Chinese women considering surgery for breast cancer have less decisional conflict and subsequent regret if they receive an educational take-home booklet to involve them in decision making, according to a study published online July 8 in the Journal of Clinical Oncology.

(HealthDay)—Chinese women considering surgery for breast cancer have less decisional conflict and subsequent regret if they receive an educational take-home booklet to involve them in decision making, according to a study published online July 8 in the Journal of Clinical Oncology.

Noting that breast cancer decision aid studies have been done in Western women for primary surgery, Wendy W.T. Lam, Ph.D., from the University of Hong Kong, and colleagues randomly assigned 276 Chinese women considering surgery for early-stage to a take-home booklet (decision aid) or the standard information booklet (control) after the initial consultation.

Based on interview-based questionnaires, the researchers found that decisional conflict scores were significantly lower for the decision-aid group one week after consultation. The decision-aid group also had significantly lower decision regret scores four and 10 months after surgery and significantly lower depression scores 10 months after surgery.

"Use of this decision aid was associated with reductions in decisional conflict, decision regret, and depression over time without increasing among Chinese women," Lam and colleagues write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Young breast cancer patients often opt for mastectomy

May 30, 2013

A new study of young women with breast cancer has found that most chose to have a mastectomy rather than a surgical procedure that would conserve the breast, researchers will report at the 49th Annual Meeting of the American ...

Recommended for you

Blood biomarker may detect lung cancer

3 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

ACG: Recent increase in incidence of young-onset CRC

19 hours ago

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments